These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34855509)

  • 1. 4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.
    Sourimant J; Lieber CM; Aggarwal M; Cox RM; Wolf JD; Yoon JJ; Toots M; Ye C; Sticher Z; Kolykhalov AA; Martinez-Sobrido L; Bluemling GR; Natchus MG; Painter GR; Plemper RK
    Science; 2022 Jan; 375(6577):161-167. PubMed ID: 34855509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4'-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replication.
    Sourimant J; Lieber CM; Aggarwal M; Cox RM; Wolf JD; Yoon JJ; Toots M; Ye C; Sticher Z; Kolykhalov AA; Martinez-Sobrido L; Bluemling GR; Natchus MG; Painter GR; Plemper RK
    bioRxiv; 2021 May; ():. PubMed ID: 34031658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
    Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex.
    Cox RM; Toots M; Yoon JJ; Sourimant J; Ludeke B; Fearns R; Bourque E; Patti J; Lee E; Vernachio J; Plemper RK
    J Biol Chem; 2018 Oct; 293(43):16761-16777. PubMed ID: 30206124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
    Lieber CM; Kang H-J; Sobolik EB; Sticher ZM; Ngo VL; Gewirtz AT; Kolykhalov AA; Natchus MG; Greninger AL; Suthar MS; Plemper RK
    J Virol; 2024 Sep; 98(9):e0090524. PubMed ID: 39207133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses.
    Lieber CM; Aggarwal M; Yoon JJ; Cox RM; Kang HJ; Sourimant J; Toots M; Johnson SK; Jones CA; Sticher ZM; Kolykhalov AA; Saindane MT; Tompkins SM; Planz O; Painter GR; Natchus MG; Sakamoto K; Plemper RK
    PLoS Pathog; 2023 Apr; 19(4):e1011342. PubMed ID: 37068076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase.
    Fearns R; Deval J
    Antiviral Res; 2016 Oct; 134():63-76. PubMed ID: 27575793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
    Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.
    Deval J; Hong J; Wang G; Taylor J; Smith LK; Fung A; Stevens SK; Liu H; Jin Z; Dyatkina N; Prhavc M; Stoycheva AD; Serebryany V; Liu J; Smith DB; Tam Y; Zhang Q; Moore ML; Fearns R; Chanda SM; Blatt LM; Symons JA; Beigelman L
    PLoS Pathog; 2015 Jun; 11(6):e1004995. PubMed ID: 26098424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
    Brookes DW; Coates M; Allen H; Daly L; Constant S; Huang S; Hows M; Davis A; Cass L; Ayrton J; Knowles I; Strong P; Rapeport G; Ito K
    Br J Pharmacol; 2018 Jun; 175(12):2520-2534. PubMed ID: 29579332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium.
    Mirabelli C; Jaspers M; Boon M; Jorissen M; Koukni M; Bardiot D; Chaltin P; Marchand A; Neyts J; Jochmans D
    J Antimicrob Chemother; 2018 Jul; 73(7):1823-1829. PubMed ID: 29596680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication.
    Murray J; Bergeron HC; Jones LP; Reener ZB; Martin DE; Sancilio FD; Tripp RA
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge.
    Hartwig SM; Odle A; Wong L-YR; Meyerholz DK; Perlman S; Varga SM
    J Virol; 2024 Sep; 98(9):e0066924. PubMed ID: 39194251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.
    Sun Y; Jain D; Koziol-White CJ; Genoyer E; Gilbert M; Tapia K; Panettieri RA; Hodinka RL; López CB
    PLoS Pathog; 2015 Sep; 11(9):e1005122. PubMed ID: 26336095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
    Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
    Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
    Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
    Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.
    Yoon JJ; Toots M; Lee S; Lee ME; Ludeke B; Luczo JM; Ganti K; Cox RM; Sticher ZM; Edpuganti V; Mitchell DG; Lockwood MA; Kolykhalov AA; Greninger AL; Moore ML; Painter GR; Lowen AC; Tompkins SM; Fearns R; Natchus MG; Plemper RK
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.